NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,052 | -92.1% | 20,952 | -56.0% | 0.00% | -90.9% |
| Q3 2022 | $152,000 | +1281.8% | 47,596 | +1537.9% | 0.01% | +1000.0% |
| Q2 2022 | $11,000 | +1000.0% | 2,906 | +1353.0% | 0.00% | – |
| Q1 2022 | $1,000 | -92.9% | 200 | -74.9% | 0.00% | -100.0% |
| Q3 2021 | $14,000 | -60.0% | 797 | -47.8% | 0.00% | -80.0% |
| Q2 2020 | $35,000 | -82.7% | 1,528 | -83.7% | 0.01% | -75.0% |
| Q4 2019 | $202,000 | -76.8% | 9,363 | -47.4% | 0.02% | -66.1% |
| Q2 2018 | $869,000 | +219.5% | 17,813 | +12.2% | 0.06% | +96.7% |
| Q3 2016 | $272,000 | -62.7% | 15,882 | -73.7% | 0.03% | -70.0% |
| Q3 2014 | $729,000 | +40.2% | 60,448 | +48.8% | 0.10% | +22.0% |
| Q2 2014 | $520,000 | +51900.0% | 40,637 | +40537.0% | 0.08% | – |
| Q4 2013 | $1,000 | -97.9% | 100 | -97.8% | 0.00% | -100.0% |
| Q3 2013 | $48,000 | – | 4,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |